BPA Call 36C24223A0015-36C24224N0378

Award Date 6/1/24
Potential Completion Date 12/31/24
Potential Value Not listed
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Hazelwood, MO 63042, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Health Agency (DHA), a component of the U.S. Department of Defense, to INO Therapeutics LLC, a company that provides inhaled nitric oxide therapy systems and related medical gases. The contract is for the delivery of NITRIC OXIDE MEDICAL GAS with an ultimate completion date of September 30, 2024 and a ceiling value of $29,571.60. The contract was awarded without a set-aside designation and is under the Pharmaceuticals and Drugs GSA...
This delivery order is a renewal of nitric oxide respiratory gas for the period of October 1, 2019 through September 30, 2020 awarded under the Department of the Army Medical Command's Pharmaceuticals and Drugs GSA Schedule. The $145,541.92 firm fixed price contract was awarded to INO Therapeutics LLC located in Hampton, New Jersey to supply respiratory gases without a set-aside designation. As the Army's medical command supports soldier healthcare, this order is likely providing critical gas...
This is a firm fixed-price delivery order awarded by the U.S. Medical Command (MEDCOM) to INO Therapeutics LLC, a prime contractor that provides inhaled nitric oxide therapy systems and related medical gases to U.S. government agencies. The $148,092.00 contract is for the delivery of nitric oxide 800PPM gas to support healthcare programs at the San Antonio Military Medical Center (SAMMC). The award was made under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) without any...
INO Therapeutics LLC has been awarded a $100,028.75 firm fixed price delivery order against the Pharmaceuticals and Drugs GSA Supply Schedule to provide nitric oxide respiratory gas from October 1, 2020 to September 30, 2021 for the Department of the Army Medical Command. As the prime contractor, INO Therapeutics will supply inhaled nitric oxide therapy systems and related medical gases to support respiratory treatments at the place of performance in Hampton, New Jersey. INO Therapeutics...
This is a Delivery Order contract awarded by the Defense Health Agency (DHA) to INO Therapeutics LLC, a prime contractor, to provide Nitric Oxide Therapy Services. The contract is a Firm Fixed Price arrangement valued at $295,518.66 and has an ultimate completion date of September 30, 2025. It was awarded on January 1, 2021 under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB) without any set-aside designation. INO Therapeutics is a foreign-owned, for-profit organization that has...
INO Therapeutics LLC has been awarded a $79,271 firm fixed price delivery order contract by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 to provide nitric oxide therapeutic gas services. The contract was awarded off the Pharmaceuticals and Drugs GSA Supply Schedule without a set-aside designation. INO Therapeutics will supply nitric oxide cylinders, gases, delivery machines, labor, and equipment to support respiratory treatments at VA...
The Department of the Army Medical Command awarded a $11,179.69 firm fixed price delivery order to Linde Gas Therapeutics GMBH of Almanya, Germany, for the purchase of nitric oxide inhalation therapy, trade name INOMAX, at a concentration of 800 parts per million. The contract has a completion date of September 30, 2020 and was awarded on October 1, 2019 without a set-aside designation. The delivery order was issued against an existing vehicle or blanket purchase agreement held by the awardee to...
This delivery order, awarded by the Department of the Army Medical Command to INO Therapeutics LLC, is for the purchase of nitric oxide respiratory gas from October 1, 2018 through September 30, 2019. The firm fixed price contract, valued at one hundred forty-nine thousand eight hundred ninety dollars and eighty cents ($149,890.80), utilizes the Pharmaceuticals and Drugs schedule under the General Services Administration (GSA) multiple award schedule contracts to acquire the product, with...
INO Therapeutics LLC was awarded a firm fixed price blanket purchase agreement (BPA) call contract from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 2. The contract is valued at thirty thousand forty-one dollars and seventy-nine cents ($30,041.79) to provide INOMAX nitric oxide gas cylinder delivery service from October 1, 2022 through September 30, 2023. No set-aside designation was applied to this award to supply medical gases in support...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 20 awarded a $9,260.58 delivery order contract to INO Therapeutics LLC for nitric oxide gas services. The contract was awarded against INO Therapeutics' GSA Schedule Pharmaceuticals and Drugs master contract vehicle. Performance will take place in Hampton, New Jersey over a one-year base period from September 1, 2023 through August 31, 2024. The firm fixed price contract calls for INO...

NITROUS OXIDE GAS (INOTHERAPY) - OPTION YEAR 1 ORDER

Posted 3/3/25, 12:00 AM